Daniela Pende

Genoa, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 57 publications

Human NK cells and cancer.

Human NK cells and cancer.

Journal: Oncoimmunology
Published: July 18, 2024

TCRαβ/CD19 cell-depleted HLA-haploidentical transplantation to treat pediatric acute leukemia: updated final analysis.

TCRαβ/CD19 cell-depleted HLA-haploidentical transplantation to treat pediatric acute leukemia: updated final analysis.

Journal: Blood
Published: May 30, 2023

Donor selection for adoptive immunotherapy with NK cells in AML patients: Comparison between analysis of lytic NK cell clones and phenotypical identification of alloreactive NK cell repertoire.

Donor selection for adoptive immunotherapy with NK cells in AML patients: Comparison between analysis of lytic NK cell clones and phenotypical identification of alloreactive NK cell repertoire.

Journal: Frontiers in immunology
Published: November 29, 2022

Epitope characterization of a monoclonal antibody that selectively recognizes KIR2DL1 allotypes.

Epitope characterization of a monoclonal antibody that selectively recognizes KIR2DL1 allotypes.

Journal: HLA
Published: January 12, 2022

Characterization of KIR+ NK cell subsets with a monoclonal antibody selectively recognizing KIR2DL1 and blocking the specific interaction with HLA-C.

Characterization of KIR+ NK cell subsets with a monoclonal antibody selectively recognizing KIR2DL1 and blocking the specific interaction with HLA-C.

Journal: HLA
Published: January 12, 2022

N-803: a double-edged sword in haplo-NK therapy.

N-803: a double-edged sword in haplo-NK therapy.

Journal: Blood
Published: November 10, 2021

Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia.

Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia.

Journal: Cancer immunology research
Published: October 07, 2021

ERAP1 Controls the Interaction of the Inhibitory Receptor KIR3DL1 With HLA-B51:01 by Affecting Natural Killer Cell Function.

ERAP1 Controls the Interaction of the Inhibitory Receptor KIR3DL1 With HLA-B51:01 by Affecting Natural Killer Cell Function.

Journal: Frontiers in immunology
Published: September 16, 2021

TCRαβ/CD19 depleted HSCT from an HLA-haploidentical relative to treat children with different nonmalignant disorders.

TCRαβ/CD19 depleted HSCT from an HLA-haploidentical relative to treat children with different nonmalignant disorders.

Journal: Blood advances
Published: June 25, 2021

Increasing LFA-1 Expression Enhances Immune Synapse Architecture and T Cell Receptor Signaling in Jurkat E6.1 Cells.

Increasing LFA-1 Expression Enhances Immune Synapse Architecture and T Cell Receptor Signaling in Jurkat E6.1 Cells.

Journal: Frontiers in cell and developmental biology
Published: February 27, 2021

Human NK cells, their receptors and function.

Human NK cells, their receptors and function.

Journal: European journal of immunology
Published: January 19, 2021

Inhibitory Receptors and Checkpoints in Human NK Cells, Implications for the Immunotherapy of Cancer.

Inhibitory Receptors and Checkpoints in Human NK Cells, Implications for the Immunotherapy of Cancer.

Journal: Frontiers in immunology
Published: June 26, 2020
Showing 1-12 of 57

Last Updated: 09/26/2026